Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases.

Panigrahy D, Gartung A, Yang J, Yang H, Gilligan MM, Sulciner ML, Bhasin SS, Bielenberg DR, Chang J, Schmidt BA, Piwowarski J, Fishbein A, Soler-Ferran D, Sparks MA, Staffa SJ, Sukhatme V, Hammock BD, Kieran MW, Huang S, Bhasin M, Serhan CN, Sukhatme VP.

J Clin Invest. 2019 Jun 17;129(7):2964-2979. doi: 10.1172/JCI127282. eCollection 2019 Jun 17.

2.

Aspirin-triggered proresolving mediators stimulate resolution in cancer.

Gilligan MM, Gartung A, Sulciner ML, Norris PC, Sukhatme VP, Bielenberg DR, Huang S, Kieran MW, Serhan CN, Panigrahy D.

Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6292-6297. doi: 10.1073/pnas.1804000116. Epub 2019 Mar 12.

3.

Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor.

Gartung A, Yang J, Sukhatme VP, Bielenberg DR, Fernandes D, Chang J, Schmidt BA, Hwang SH, Zurakowski D, Huang S, Kieran MW, Hammock BD, Panigrahy D.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1698-1703. doi: 10.1073/pnas.1803999116. Epub 2019 Jan 15.

4.

A paradoxical method to enhance compensatory lung growth: Utilizing a VEGF inhibitor.

Dao DT, Anez-Bustillos L, Jabbouri SS, Pan A, Kishikawa H, Mitchell PD, Fell GL, Baker MA, Watnick RS, Chen H, Rogers MS, Bielenberg DR, Puder M.

PLoS One. 2018 Dec 19;13(12):e0208579. doi: 10.1371/journal.pone.0208579. eCollection 2018.

5.

Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a Critical Mediator of Tissue Repair and Regeneration.

Dao DT, Anez-Bustillos L, Adam RM, Puder M, Bielenberg DR.

Am J Pathol. 2018 Nov;188(11):2446-2456. doi: 10.1016/j.ajpath.2018.07.016. Epub 2018 Aug 22. Review.

PMID:
30142332
6.

Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes.

Wu H, Rahman HNA, Dong Y, Liu X, Lee Y, Wen A, To KH, Xiao L, Birsner AE, Bazinet L, Wong S, Song K, Brophy ML, Mahamud MR, Chang B, Cai X, Pasula S, Kwak S, Yang W, Bischoff J, Xu J, Bielenberg DR, Dixon JB, D'Amato RJ, Srinivasan RS, Chen H.

J Clin Invest. 2018 Aug 31;128(9):4025-4043. doi: 10.1172/JCI96063. Epub 2018 Aug 13.

7.

Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin.

Chang J, Bhasin SS, Bielenberg DR, Sukhatme VP, Bhasin M, Huang S, Kieran MW, Panigrahy D.

FASEB J. 2019 Jan;33(1):114-125. doi: 10.1096/fj.201800019RR. Epub 2018 Jun 29.

8.

Heparin impairs angiogenic signaling and compensatory lung growth after left pneumonectomy.

Dao DT, Anez-Bustillos L, Ourieff J, Pan A, Mitchell PD, Kishikawa H, Fell GL, Baker MA, Watnick RS, Chen H, Hamilton TE, Rogers MS, Bielenberg DR, Puder M.

Angiogenesis. 2018 Nov;21(4):837-848. doi: 10.1007/s10456-018-9628-3. Epub 2018 Jun 28.

9.

Intranasal delivery of VEGF enhances compensatory lung growth in mice.

Dao DT, Vuong JT, Anez-Bustillos L, Pan A, Mitchell PD, Fell GL, Baker MA, Bielenberg DR, Puder M.

PLoS One. 2018 Jun 7;13(6):e0198700. doi: 10.1371/journal.pone.0198700. eCollection 2018.

10.

Resolvins suppress tumor growth and enhance cancer therapy.

Sulciner ML, Serhan CN, Gilligan MM, Mudge DK, Chang J, Gartung A, Lehner KA, Bielenberg DR, Schmidt B, Dalli J, Greene ER, Gus-Brautbar Y, Piwowarski J, Mammoto T, Zurakowski D, Perretti M, Sukhatme VP, Kaipainen A, Kieran MW, Huang S, Panigrahy D.

J Exp Med. 2018 Jan 2;215(1):115-140. doi: 10.1084/jem.20170681. Epub 2017 Nov 30.

11.

Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization.

Hasegawa E, Inafuku S, Mulki L, Okunuki Y, Yanai R, Smith KE, Kim CB, Klokman G, Bielenberg DR, Puli N, Falck JR, Husain D, Miller JW, Edin ML, Zeldin DC, Lee KSS, Hammock BD, Schunck WH, Connor KM.

Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):E7545-E7553. doi: 10.1073/pnas.1620898114. Epub 2017 Aug 21.

12.

Identification of RUNX1 as a Mediator of Aberrant Retinal Angiogenesis.

Lam JD, Oh DJ, Wong LL, Amarnani D, Park-Windhol C, Sanchez AV, Cardona-Velez J, McGuone D, Stemmer-Rachamimov AO, Eliott D, Bielenberg DR, van Zyl T, Shen L, Gai X, D'Amore PA, Kim LA, Arboleda-Velasquez JF.

Diabetes. 2017 Jul;66(7):1950-1956. doi: 10.2337/db16-1035. Epub 2017 Apr 11.

13.

A quantitative method for screening and identifying molecular targets for nanomedicine.

Guo P, Yang J, Bielenberg DR, Dillon D, Zurakowski D, Moses MA, Auguste DT.

J Control Release. 2017 Oct 10;263:57-67. doi: 10.1016/j.jconrel.2017.03.030. Epub 2017 Mar 22.

14.

Deletion of neuropilin 2 enhances detrusor contractility following bladder outlet obstruction.

Vasquez E, Cristofaro V, Lukianov S, Burkhard FC, Gheinani AH, Monastyrskaya K, Bielenberg DR, Sullivan MP, Adam RM.

JCI Insight. 2017 Feb 9;2(3):e90617. doi: 10.1172/jci.insight.90617.

15.

The intragraft microenvironment as a central determinant of chronic rejection or local immunoregulation/tolerance.

Wedel J, Nakayama H, Kochupurakkal NM, Koch J, Klagsbrun M, Bielenberg DR, Briscoe DM.

Curr Opin Organ Transplant. 2017 Feb;22(1):55-63. doi: 10.1097/MOT.0000000000000373. Review.

16.

Inflammation and Lymphedema Are Exacerbated and Prolonged by Neuropilin 2 Deficiency.

Mucka P, Levonyak N, Geretti E, Zwaans BMM, Li X, Adini I, Klagsbrun M, Adam RM, Bielenberg DR.

Am J Pathol. 2016 Nov;186(11):2803-2812. doi: 10.1016/j.ajpath.2016.07.022. Epub 2016 Oct 14.

17.

Endothelial epsins as regulators and potential therapeutic targets of tumor angiogenesis.

Song K, Wu H, Rahman HN, Dong Y, Wen A, Brophy ML, Wong S, Kwak S, Bielenberg DR, Chen H.

Cell Mol Life Sci. 2017 Feb;74(3):393-398. doi: 10.1007/s00018-016-2347-2. Epub 2016 Aug 29. Review.

18.

Orbital Angiogenesis and Lymphangiogenesis in Thyroid Eye Disease: An Analysis of Vascular Growth Factors with Clinical Correlation.

Wong LL, Lee NG, Amarnani D, Choi CJ, Bielenberg DR, Freitag SK, D'Amore PA, Kim LA.

Ophthalmology. 2016 Sep;123(9):2028-36. doi: 10.1016/j.ophtha.2016.05.052. Epub 2016 Jul 14.

19.

Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment.

Wang S, Blois A, El Rayes T, Liu JF, Hirsch MS, Gravdal K, Palakurthi S, Bielenberg DR, Akslen LA, Drapkin R, Mittal V, Watnick RS.

Sci Transl Med. 2016 Mar 9;8(329):329ra34. doi: 10.1126/scitranslmed.aad5653.

20.

Neuropilin 1 Receptor Is Up-Regulated in Dysplastic Epithelium and Oral Squamous Cell Carcinoma.

Shahrabi-Farahani S, Gallottini M, Martins F, Li E, Mudge DR, Nakayama H, Hida K, Panigrahy D, D'Amore PA, Bielenberg DR.

Am J Pathol. 2016 Apr;186(4):1055-64. doi: 10.1016/j.ajpath.2015.11.021. Epub 2016 Feb 11.

21.

The role of EMT and MET in cancer dissemination.

Banyard J, Bielenberg DR.

Connect Tissue Res. 2015;56(5):403-13. doi: 10.3109/03008207.2015.1060970. Epub 2015 Aug 20. Review.

22.

The Contribution of Angiogenesis to the Process of Metastasis.

Bielenberg DR, Zetter BR.

Cancer J. 2015 Jul-Aug;21(4):267-73. doi: 10.1097/PPO.0000000000000138. Review.

23.

Melanocyte pigmentation inversely correlates with MCP-1 production and angiogenesis-inducing potential.

Adini I, Adini A, Bazinet L, Watnick RS, Bielenberg DR, D'Amato RJ.

FASEB J. 2015 Feb;29(2):662-70. doi: 10.1096/fj.14-255398. Epub 2014 Nov 18.

24.

Lymphatics in development and pathology: introduction to a special issue of Microvascular Research.

Bielenberg DR, D'Amore PA.

Microvasc Res. 2014 Nov;96:1-2. doi: 10.1016/j.mvr.2014.09.001. Epub 2014 Sep 6. No abstract available.

PMID:
25200924
25.

Lymphangiogenesis and metastasis--a closer look at the neuropilin/semaphorin3 axis.

Migliozzi MT, Mucka P, Bielenberg DR.

Microvasc Res. 2014 Nov;96:68-76. doi: 10.1016/j.mvr.2014.07.006. Epub 2014 Aug 1. Review.

26.

Regulation of soluble neuropilin 1, an endogenous angiogenesis inhibitor, in liver development and regeneration.

Panigrahy D, Adini I, Mamluk R, Levonyak N, Bruns CJ, D'Amore PA, Klagsbrun M, Bielenberg DR.

Pathology. 2014 Aug;46(5):416-23. doi: 10.1097/PAT.0000000000000121.

27.

Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer.

Banyard J, Chung I, Migliozzi M, Phan DT, Wilson AM, Zetter BR, Bielenberg DR.

BMC Cancer. 2014 May 30;14:387. doi: 10.1186/1471-2407-14-387.

28.

Neuropilin 1 expression correlates with differentiation status of epidermal cells and cutaneous squamous cell carcinomas.

Shahrabi-Farahani S, Wang L, Zwaans BM, Santana JM, Shimizu A, Takashima S, Kreuter M, Coultas L, D'Amore PA, Arbeit JM, Akslen LA, Bielenberg DR.

Lab Invest. 2014 Jul;94(7):752-65. doi: 10.1038/labinvest.2014.66. Epub 2014 May 5.

29.

Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment.

Adini I, Ghosh K, Adini A, Chi ZL, Yoshimura T, Benny O, Connor KM, Rogers MS, Bazinet L, Birsner AE, Bielenberg DR, D'Amato RJ.

J Clin Invest. 2014 Jan;124(1):425-36. doi: 10.1172/JCI69404. Epub 2013 Dec 20.

30.

Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model.

Banyard J, Chung I, Wilson AM, Vetter G, Le Béchec A, Bielenberg DR, Zetter BR.

Sci Rep. 2013 Nov 6;3:3151. doi: 10.1038/srep03151.

31.

Epoxyeicosanoids promote organ and tissue regeneration.

Panigrahy D, Kalish BT, Huang S, Bielenberg DR, Le HD, Yang J, Edin ML, Lee CR, Benny O, Mudge DK, Butterfield CE, Mammoto A, Mammoto T, Inceoglu B, Jenkins RL, Simpson MA, Akino T, Lih FB, Tomer KB, Ingber DE, Hammock BD, Falck JR, Manthati VL, Kaipainen A, D'Amore PA, Puder M, Zeldin DC, Kieran MW.

Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13528-33. doi: 10.1073/pnas.1311565110. Epub 2013 Jul 29.

32.

All vessels are not created equal.

Bielenberg DR, D'Amore PA.

Am J Pathol. 2013 Apr;182(4):1087-91. doi: 10.1016/j.ajpath.2013.01.008. Epub 2013 Feb 17. No abstract available.

33.

Netrin-1 promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein.

Shimizu A, Nakayama H, Wang P, König C, Akino T, Sandlund J, Coma S, Italiano JE Jr, Mammoto A, Bielenberg DR, Klagsbrun M.

J Biol Chem. 2013 Jan 25;288(4):2210-22. doi: 10.1074/jbc.M112.397398. Epub 2012 Nov 29.

34.

Cytoskeletal stiffness, friction, and fluidity of cancer cell lines with different metastatic potential.

Coughlin MF, Bielenberg DR, Lenormand G, Marinkovic M, Waghorne CG, Zetter BR, Fredberg JJ.

Clin Exp Metastasis. 2013 Mar;30(3):237-50. doi: 10.1007/s10585-012-9531-z. Epub 2012 Sep 8.

35.

Increased smooth muscle contractility in mice deficient for neuropilin 2.

Bielenberg DR, Seth A, Shimizu A, Pelton K, Cristofaro V, Ramachandran A, Zwaans BM, Chen C, Krishnan R, Seth M, Huang L, Takashima S, Klagsbrun M, Sullivan MP, Adam RM.

Am J Pathol. 2012 Aug;181(2):548-59. doi: 10.1016/j.ajpath.2012.04.013. Epub 2012 Jun 9.

36.

DIAPH3 governs the cellular transition to the amoeboid tumour phenotype.

Hager MH, Morley S, Bielenberg DR, Gao S, Morello M, Holcomb IN, Liu W, Mouneimne G, Demichelis F, Kim J, Solomon KR, Adam RM, Isaacs WB, Higgs HN, Vessella RL, Di Vizio D, Freeman MR.

EMBO Mol Med. 2012 Aug;4(8):743-60. doi: 10.1002/emmm.201200242. Epub 2012 May 16.

37.

α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug.

Graf N, Bielenberg DR, Kolishetti N, Muus C, Banyard J, Farokhzad OC, Lippard SJ.

ACS Nano. 2012 May 22;6(5):4530-9. doi: 10.1021/nn301148e. Epub 2012 May 14.

38.

Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice.

Panigrahy D, Edin ML, Lee CR, Huang S, Bielenberg DR, Butterfield CE, Barnés CM, Mammoto A, Mammoto T, Luria A, Benny O, Chaponis DM, Dudley AC, Greene ER, Vergilio JA, Pietramaggiori G, Scherer-Pietramaggiori SS, Short SM, Seth M, Lih FB, Tomer KB, Yang J, Schwendener RA, Hammock BD, Falck JR, Manthati VL, Ingber DE, Kaipainen A, D'Amore PA, Kieran MW, Zeldin DC.

J Clin Invest. 2012 Jan;122(1):178-91. doi: 10.1172/JCI58128. Epub 2011 Dec 19.

39.

Increased endothelial progenitor cells and vasculogenic factors in higher-staged arteriovenous malformations.

Lu L, Bischoff J, Mulliken JB, Bielenberg DR, Fishman SJ, Greene AK.

Plast Reconstr Surg. 2011 Oct;128(4):260e-269e. doi: 10.1097/PRS.0b013e3182268afd.

40.

Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells.

Gregory KJ, Zhao B, Bielenberg DR, Dridi S, Wu J, Jiang W, Huang B, Pirie-Shepherd S, Fannon M.

PLoS One. 2010 Oct 18;5(10):e13428. doi: 10.1371/journal.pone.0013428.

41.

Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis.

Gaur P, Bielenberg DR, Samuel S, Bose D, Zhou Y, Gray MJ, Dallas NA, Fan F, Xia L, Lu J, Ellis LM.

Clin Cancer Res. 2009 Nov 15;15(22):6763-70. doi: 10.1158/1078-0432.CCR-09-1810. Epub 2009 Nov 3. Review.

42.

Lipocalin 2 promotes breast cancer progression.

Yang J, Bielenberg DR, Rodig SJ, Doiron R, Clifton MC, Kung AL, Strong RK, Zurakowski D, Moses MA.

Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3913-8. doi: 10.1073/pnas.0810617106. Epub 2009 Feb 23.

43.

Judah Folkman's contribution to the inhibition of angiogenesis.

Bielenberg DR, D'Amore PA.

Lymphat Res Biol. 2008;6(3-4):203-7. doi: 10.1089/lrb.2008.1016. Review. No abstract available.

PMID:
19093793
44.

Semaphorin-induced cytoskeletal collapse and repulsion of endothelial cells.

Bielenberg DR, Shimizu A, Klagsbrun M.

Methods Enzymol. 2008;443:299-314. doi: 10.1016/S0076-6879(08)02015-6.

PMID:
18772022
45.

Metastasis: two assays explore the two roads traveled.

Bielenberg DR.

Nat Methods. 2008 May;5(5):384-5. doi: 10.1038/nmeth0508-384. No abstract available.

PMID:
18446156
46.

Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells.

Amin DN, Bielenberg DR, Lifshits E, Heymach JV, Klagsbrun M.

Microvasc Res. 2008 May;76(1):15-22. doi: 10.1016/j.mvr.2008.01.002. Epub 2008 Mar 18.

PMID:
18440031
47.

Potential therapeutic strategies for lymphatic metastasis.

Zwaans BM, Bielenberg DR.

Microvasc Res. 2007 Sep-Nov;74(2-3):145-58. Epub 2007 Sep 19. Review.

48.

Targeting endothelial and tumor cells with semaphorins.

Bielenberg DR, Klagsbrun M.

Cancer Metastasis Rev. 2007 Dec;26(3-4):421-31. Review.

PMID:
17768598
49.

Behavioral profiling of human transitional cell carcinoma ex vivo.

Estrada CR, Salanga M, Bielenberg DR, Harrell WB, Zurakowski D, Zhu X, Palmer MR, Freeman MR, Adam RM.

Cancer Res. 2006 Mar 15;66(6):3078-86.

50.

Supplemental Content

Loading ...
Support Center